News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,413 Results
Type
Article (58308)
Company Profile (359)
Press Release (693746)
Section
Business (218159)
Career Advice (2844)
Deals (37545)
Drug Delivery (101)
Drug Development (86285)
Employer Resources (181)
FDA (17216)
Job Trends (16166)
News (370344)
Policy (36463)
Tag
Academia (2929)
Africa (974)
Alliances (53223)
Alzheimer's disease (1253)
Approvals (17132)
Arizona (200)
Artificial intelligence (98)
Asia (42752)
Australia (7719)
Bankruptcy (378)
Best Places to Work (12166)
Biotechnology (240)
Breast cancer (81)
C2C Services and Suppliers (87484)
California (2214)
Canada (1026)
Cancer (674)
Career advice (2384)
Cell therapy (166)
China (172)
Clinical research (67589)
Collaboration (213)
Colorado (92)
Compensation (114)
Connecticut (96)
COVID-19 (2741)
Cystic fibrosis (82)
Data (485)
Diabetes (106)
Diagnostics (6503)
Drug pricing (94)
Earnings (86843)
Employer resources (155)
Europe (95218)
Events (119815)
Executive appointments (195)
FDA (17531)
Florida (316)
Funding (195)
Gene therapy (123)
Georgia (79)
GLP-1 (614)
Government (4957)
Healthcare (20403)
Hotbed/Location (511175)
Illinois (313)
Indiana (165)
Infectious disease (2785)
Inflammatory bowel disease (101)
Interviews (549)
IPO (16859)
Job creations (4215)
Job search strategy (1985)
Kansas (97)
Layoffs (450)
Legal (8911)
Lung cancer (137)
Manufacturing (125)
Maryland (469)
Massachusetts (1839)
Medical device (13981)
Medtech (13986)
Mergers & acquisitions (20584)
Metabolic disorders (327)
Michigan (147)
Minnesota (243)
Neuroscience (1458)
New Jersey (686)
New York (690)
NextGen Class of 2024 (7291)
Non-profit (4990)
North Carolina (697)
Northern California (948)
Obesity (197)
Ohio (118)
Opinion (220)
Patents (88)
Pennsylvania (639)
People (61272)
Pharmaceutical (81)
Phase I (20883)
Phase II (29570)
Phase III (22193)
Pipeline (143)
Postmarket research (3037)
Preclinical (8990)
Radiopharmaceuticals (252)
Rare diseases (165)
Real estate (6522)
Regulatory (23726)
Research institute (2587)
Resumes & cover letters (451)
South America (1347)
Southern California (886)
Startups (3948)
Texas (289)
United States (10040)
Vaccines (572)
Washington State (279)
Weight loss (171)
Date
Last 7 days (682)
Last 30 days (2668)
Last 365 days (38578)
2024 (29041)
2023 (42114)
2022 (53384)
2021 (58186)
2020 (57163)
2019 (50605)
2018 (38428)
2017 (35055)
2016 (35386)
2015 (41501)
2014 (35531)
2013 (30999)
2012 (32988)
2011 (33548)
2010 (31994)
752,413 Results for "trividia health formerly known as nipro diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Allez Health Announces $60 Million Capital Raise
Allez Health Inc., formerly known as Zense-Life Inc., an emerging biosensor venture founded by proven experts in the continuous glucose monitoring space, announced a $60 million Series A+ financing.
May 22, 2024
·
2 min read
Deals
Quest Diagnostics to Acquire Select Lab Assets from Allina Health
Quest Diagnostics and Allina Health announced a definitive agreement for Quest to acquire select laboratory assets from Allina Health, with the goal to improve access to and the affordability of innovative laboratory services across Minnesota and western Wisconsin.
June 26, 2024
·
2 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Press Releases
Labcorp Completes Acquisition of Select Assets of BioReference Health’s Diagnostics Business from OPKO Health
September 16, 2024
·
5 min read
Business
DiaCarta and Capstone Health Alliance Collaborate to Bring Revolutionary Diagnostic Tests to Enhance Patient Care
DiaCarta, Inc. (“DiaCarta”), a pioneer in developing innovative molecular technologies to transform patient care by providing effective precision diagnostics using liquid biopsy in cancer and infectious diseases has established a strategic collaboration with Capstone Health Alliance, one of the largest regional group purchasing organizations (GPO) in the US healthcare sector.
June 26, 2024
·
3 min read
Deals
Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business
Labcorp and OPKO Health, Inc. announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
March 28, 2024
·
7 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Policy
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.
June 25, 2024
·
6 min read
Biotech Beach
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 13-14, 2024 in Snowbird, Utah.
January 30, 2024
·
1 min read
Pharm Country
New CHOP Research Links Genetics, Environment and Health Disparities to Increased Stress and Mental Health Challenges During Adolescence
A new study from researchers at Children’s Hospital of Philadelphia reveals that the cumulative “wear and tear” on the body known as allostatic load can be measured in early adolescence and that childhood adversity correlates with increased stress and mental health challenges during adolescence.
May 14, 2024
·
4 min read
1 of 75,242
Next